SAD/MAD of ABX-002-1902 Investigating the Safety, Pharmacokinetics/Pharmacodynamics of in Healthy Subjects
Clinical trial NCT05528315 · COMPLETED
Trial details
- NCT number
- NCT05528315
- Sponsor
- Autobahn Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-12
- Primary completion
- 2023-06-26
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.